FDA approves darunavir.
D000328:Adult; D000069454:Darunavir; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000069454:Darunavir